Evolus, Inc. (NASDAQ:EOLS)
Industry: Drug Manufacturers - Specialty & Generic

Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Current Quote*
Last: $8.650
Change: 0.000
Book: $Unk
Volume: 555,216

As Of: 08/19 16:04 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol EOLS

Graphs for EOLS


3 Month Graph


6 Month Graph


1 Year Graph